Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings.

Luetkemeyer AF, Firnhaber C, Kendall MA, Wu X, Mazurek GH, Benator DA, Arduino R, Fernandez M, Guy E, Johnson P, Metchock B, Sattler F, Telzak E, Wang YF, Weiner M, Swindells S, Sanne IM, Havlir DV, Grinsztejn B, Alland D; AIDS Clinical Trials Group A5295 and Tuberculosis Trials Consortium Study 34 Teams.

Clin Infect Dis. 2016 May 1;62(9):1081-8. doi: 10.1093/cid/ciw035. Epub 2016 Feb 2.

PMID:
26839383
2.

Testosterone Supplementation Improves Carbohydrate and Lipid Metabolism in Some Older Men with Abdominal Obesity.

Sattler F, He J, Chukwuneke J, Kim H, Stewart Y, Colletti P, Yarasheski K, Buchanan T.

J Gerontol Geriatr Res. 2014 Jun 7;3(3):1000159.

3.

Sequential bilateral testicular tumours presenting with intervals of 20 years and more.

Dieckmann KP, Anheuser P, Sattler F, Von Kügelgen T, Matthies C, Ruf C.

BMC Urol. 2013 Dec 9;13:71. doi: 10.1186/1471-2490-13-71.

4.

Relationship of Acute Phase Reactants and Fat Accumulation during Treatment for Tuberculosis.

Sanchez A, Azen C, Jones B, Louie S, Sattler F.

Tuberc Res Treat. 2011;2011:346295. doi: 10.1155/2011/346295. Epub 2011 Sep 13.

5.

Testosterone threshold levels and lean tissue mass targets needed to enhance skeletal muscle strength and function: the HORMA trial.

Sattler F, Bhasin S, He J, Chou CP, Castaneda-Sceppa C, Yarasheski K, Binder E, Schroeder ET, Kawakubo M, Zhang A, Roubenoff R, Azen S.

J Gerontol A Biol Sci Med Sci. 2011 Jan;66(1):122-9. doi: 10.1093/gerona/glq183. Epub 2010 Nov 8.

6.

Estimation of glomerular filtration rate by using serum cystatin C and serum creatinine concentrations in patients with human immunodeficiency virus.

Beringer PM, Owens H, Nguyen A, Mordwinkin N, Louie S, Mak M, Sattler F.

Pharmacotherapy. 2010 Oct;30(10):1004-10. doi: 10.1592/phco.30.10.1004.

PMID:
20874037
7.

The Double Sensor-A non-invasive device to continuously monitor core temperature in humans on earth and in space.

Gunga HC, Werner A, Stahn A, Steinach M, Schlabs T, Koralewski E, Kunz D, Belavý DL, Felsenberg D, Sattler F, Koch J.

Respir Physiol Neurobiol. 2009 Oct;169 Suppl 1:S63-8. doi: 10.1016/j.resp.2009.04.005. Epub 2009 Apr 14.

PMID:
19428314
8.

Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s).

Tebas P, Zhang J, Yarasheski K, Evans S, Fischl MA, Shevitz A, Feinberg J, Collier AC, Shikuma C, Brizz B, Sattler F; AIDS Clinical Trials Group (ACTG).

J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):193-200.

9.

Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.

Bhasin S, Parker RA, Sattler F, Haubrich R, Alston B, Umbleja T, Shikuma CM; AIDS Clinical Trials Group Protocol A5079 Study Team.

J Clin Endocrinol Metab. 2007 Mar;92(3):1049-57. Epub 2006 Dec 12.

PMID:
17164307
10.

A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment.

Storer TW, Woodhouse LJ, Sattler F, Singh AB, Schroeder ET, Beck K, Padero M, Mac P, Yarasheski KE, Geurts P, Willemsen A, Harms MK, Bhasin S.

J Clin Endocrinol Metab. 2005 Aug;90(8):4474-82. Epub 2005 May 24.

PMID:
15914526
11.

A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitis.

Borucki MJ, Spritzler J, Asmuth DM, Gnann J, Hirsch MS, Nokta M, Aweeka F, Nadler PI, Sattler F, Alston B, Nevin TT, Owens S, Waterman K, Hubbard L, Caliendo A, Pollard RB; AACTG 266 Team.

Antiviral Res. 2004 Nov;64(2):103-11.

PMID:
15498605
12.

Changes in weight and lean body mass during highly active antiretroviral therapy.

Shikuma CM, Zackin R, Sattler F, Mildvan D, Nyangweso P, Alston B, Evans S, Mulligan K; AIDS Clinical Trial Group 892 Team.

Clin Infect Dis. 2004 Oct 15;39(8):1223-30. Epub 2004 Sep 27.

13.

Body habitus changes related to lipodystrophy.

Sattler F.

Clin Infect Dis. 2003 Apr 1;36(Suppl 2):S84-90.

14.

Low dihydrotestosterone and weight loss in the AIDS wasting syndrome.

Sattler F, Briggs W, Antonipillai I, Allen J, Horton R.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Jul 1;18(3):246-51.

PMID:
9665502
15.

The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women.

Sinha-Hikim I, Arver S, Beall G, Shen R, Guerrero M, Sattler F, Shikuma C, Nelson JC, Landgren BM, Mazer NA, Bhasin S.

J Clin Endocrinol Metab. 1998 Apr;83(4):1312-8. Erratum in: J Clin Endocrinol Metab 1998 Aug;83(8):2959.

PMID:
9543161
16.

Nonspecific interstitial pneumonitis mimicking Pneumocystis carinii pneumonia.

Sattler F, Nichols L, Hirano L, Hiti A, Hofman F, Hughlett C, Zeng L, Boylen CT, Koss M.

Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):912-7.

PMID:
9310013
17.

Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.

Jacobson MA, Zegans M, Pavan PR, O'Donnell JJ, Sattler F, Rao N, Owens S, Pollard R.

Lancet. 1997 May 17;349(9063):1443-5.

PMID:
9164318
18.

High-dose recombinant endotoxin neutralizing protein improves survival in rabbits, with Escherichia coli sepsis.

Saladino RA, Stack AM, Thompson C, Sattler F, Novitsky TJ, Siber GR, Fleisher GR.

Crit Care Med. 1996 Jul;24(7):1203-7.

PMID:
8674336
19.

A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection.

Markowitz M, Saag M, Powderly WG, Hurley AM, Hsu A, Valdes JM, Henry D, Sattler F, La Marca A, Leonard JM, et al.

N Engl J Med. 1995 Dec 7;333(23):1534-9.

20.

Failure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor monoclonal antibody in Escherichia coli sepsis in the rabbit.

Stack AM, Saladino RA, Thompson C, Sattler F, Weiner DL, Parsonnet J, Nariuchi H, Siber GR, Fleisher GR.

Crit Care Med. 1995 Sep;23(9):1512-8.

PMID:
7664553
Items per page

Supplemental Content

Loading ...
Write to the Help Desk